GAGE2B | G antigen 2B | Xp11.23 not on reference assembly | 2.001 | 0.44 | 0
|
GAGE1 | G antigen 1 | Xp11.23 | 1.884 | 0.4 | 0
|
LINC00200 | long intergenic non-protein coding RNA 200 | 10p15.3 | 1.869 | 0.375 | 1.04e-15
|
DPPA2 | developmental pluripotency associated 2 | 3q13.13 | 1.855 | 0.351 | 1.06e-13
|
GAGE2A | G antigen 2A | Xp11.23 | 1.81 | 0.375 | 8.92e-16
|
PAGE2 | P antigen family, member 2 (prostate associated) | Xp11.22 | 1.802 | 0.426 | 0
|
GAGE12D | G antigen 12D | Xp11.23 | 1.785 | 0.407 | 0
|
NAA11 | N(alpha)-acetyltransferase 11, NatA catalytic subunit | 4q21.23 | 1.779 | 0.44 | 0
|
FTHL17 | ferritin, heavy polypeptide-like 17 | Xp21.2 | 1.756 | 0.403 | 0
|
GC | group-specific component (vitamin D binding protein) | 4q12-q13 | 1.752 | 0.374 | 1.26e-15
|
MMP23A | matrix metallopeptidase 23A (pseudogene) | 1p36.3 | 1.746 | 0.336 | 1.35e-12
|
APOC3 | apolipoprotein C-III | 11q23.3 | 1.729 | 0.303 | 1.91e-10
|
SSX2 | synovial sarcoma, X breakpoint 2 | Xp11.22 | 1.718 | 0.359 | 2.53e-14
|
XAGE2 | X antigen family, member 2 | Xp11.22 | 1.714 | 0.354 | 6.69e-14
|
GAGE12J | G antigen 12J | Xp11.23 | 1.699 | 0.388 | 0
|
APOH | apolipoprotein H (beta-2-glycoprotein I) | 17q24.2 | 1.698 | 0.358 | 3.36e-14
|
GAGE2D | G antigen 2D | Xp11.23 not on reference assembly | 1.696 | 0.413 | 0
|
DCAF4L2 | DDB1 and CUL4 associated factor 4-like 2 | 8q21.3 | 1.685 | 0.333 | 2.21e-12
|
SPANXC | SPANX family, member C | Xq27.2 | 1.683 | 0.252 | 1.42e-07
|
SSX1 | synovial sarcoma, X breakpoint 1 | Xp11.23 | 1.677 | 0.405 | 0
|
NXF2 | nuclear RNA export factor 2 | Xq22.1 | 1.675 | 0.311 | 6.53e-11
|
ZNF716 | zinc finger protein 716 | 7p11.1 | 1.665 | 0.362 | 1.57e-14
|
DSCR4 | Down syndrome critical region 4 | 21q22.2 | 1.651 | 0.443 | 0
|
REG1A | regenerating islet-derived 1 alpha | 2p12 | 1.645 | 0.272 | 1.34e-08
|
CT83 | cancer/testis antigen 83 | Xq23 | 1.639 | 0.367 | 5.22e-15
|
PHF2P1 | PHD finger protein 2 pseudogene 1 | 13q11 | 1.636 | 0.368 | 4.48e-15
|
GAGE4 | G antigen 4 | Xp11.4-p11.2 not on reference assembly | 1.634 | 0.385 | 3.33e-17
|
CT45A5 | cancer/testis antigen family 45, member A5 | Xq26.3 | 1.627 | 0.357 | 3.8e-14
|
PPP4R3CP | protein phosphatase 4, regulatory subunit 3C, pseudogene | Xp21.3 | 1.616 | 0.313 | 4.92e-11
|
HMX1 | H6 family homeobox 1 | 4p16.1 | 1.597 | 0.227 | 2.39e-06
|
DLK1 | delta-like 1 homolog (Drosophila) | 14q32.2 | 1.595 | 0.167 | 0.000526
|
SAGE1 | sarcoma antigen 1 | Xq26 | 1.587 | 0.414 | 0
|
TUBA3C | tubulin, alpha 3c | 13q12.11 | 1.574 | 0.368 | 4.03e-15
|
LCN15 | lipocalin 15 | 9q34.3 | 1.565 | 0.302 | 2.23e-10
|
CT45A1 | cancer/testis antigen family 45, member A1 | Xq26.3 | 1.561 | 0.334 | 1.74e-12
|
KLK3 | kallikrein-related peptidase 3 | 19q13.41 | 1.518 | 0.252 | 1.4e-07
|
CDH18 | cadherin 18, type 2 | 5p14.3 | 1.517 | 0.281 | 4.2e-09
|
SSX4 | synovial sarcoma, X breakpoint 4 | Xp11.23 | 1.511 | 0.334 | 1.88e-12
|
FOXG1 | forkhead box G1 | 14q12 | 1.509 | 0.285 | 2.37e-09
|
PRAC1 | prostate cancer susceptibility candidate 1 | 17q21 | 1.508 | 0.187 | 0.000103
|
PIWIL3 | piwi-like RNA-mediated gene silencing 3 | 22q11.23 | 1.492 | 0.304 | 1.68e-10
|
CELP | carboxyl ester lipase pseudogene | 9q34.2 | 1.478 | 0.171 | 0.000393
|
SPRR2B | small proline-rich protein 2B | 1q21-q22 | 1.451 | 0.197 | 4.29e-05
|
DPP10 | dipeptidyl-peptidase 10 (non-functional) | 2q14.1 | 1.435 | 0.231 | 1.56e-06
|
TRDN | triadin | 6q22.31 | 1.429 | 0.268 | 2.1e-08
|
CRISP2 | cysteine-rich secretory protein 2 | 6p12.3 | 1.426 | 0.225 | 2.7e-06
|
BPIFA1 | BPI fold containing family A, member 1 | 20q11.21 | 1.424 | 0.142 | 0.00328
|
C14orf180 | chromosome 14 open reading frame 180 | 14q32.33 | 1.41 | 0.205 | 2.09e-05
|
TCHHL1 | trichohyalin-like 1 | 1q21.3 | 1.409 | 0.182 | 0.000158
|
ZIC1 | Zic family member 1 | 3q24 | 1.397 | 0.295 | 6.16e-10
|
LCE3E | late cornified envelope 3E | 1q21.3 | 1.39 | 0.208 | 1.57e-05
|
AHSG | alpha-2-HS-glycoprotein | 3q27.3 | 1.384 | 0.278 | 6e-09
|
TMPRSS11F | transmembrane protease, serine 11F | 4q13.2 | 1.382 | 0.048 | 0.321
|
PRSS41 | protease, serine, 41 | 16p13.3 | 1.358 | 0.2 | 3.17e-05
|
SERPINA4 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 4 | 14q32.13 | 1.345 | 0.206 | 1.95e-05
|
ADIPOQ | adiponectin, C1Q and collagen domain containing | 3q27 | 1.34 | 0.134 | 0.00552
|
ZNF560 | zinc finger protein 560 | 19p13.2 | 1.336 | 0.264 | 3.67e-08
|
NPHS2 | nephrosis 2, idiopathic, steroid-resistant (podocin) | 1q25.2 | 1.336 | 0.247 | 2.52e-07
|
AADACL2 | arylacetamide deacetylase-like 2 | 3q25.1 | 1.335 | 0.202 | 2.82e-05
|
PNLIPRP3 | pancreatic lipase-related protein 3 | 10q26.12 | 1.331 | 0.103 | 0.0327
|
SPRR2C | small proline-rich protein 2C (pseudogene) | 1q21-q22 | 1.316 | 0.162 | 0.000774
|
LINC00202-2 | long intergenic non-protein coding RNA 202-2 | 10p12.1 | 1.302 | 0.307 | 1.15e-10
|
AQP4 | aquaporin 4 | 18q11.2-q12.1 | 1.302 | 0.11 | 0.0231
|
PAGE2B | P antigen family, member 2B | Xp11.22 | 1.294 | 0.286 | 2.05e-09
|
PPY2P | pancreatic polypeptide 2, pseudogene | 17q11.2 | 1.293 | 0.346 | 2.38e-13
|
HBE1 | hemoglobin, epsilon 1 | 11p15.5 | 1.282 | 0.23 | 1.65e-06
|
PAX3 | paired box 3 | 2q36.1 | 1.279 | 0.193 | 5.88e-05
|
LRTM1 | leucine-rich repeats and transmembrane domains 1 | 3p14.3 | 1.259 | 0.183 | 0.000146
|
QRFPR | pyroglutamylated RFamide peptide receptor | 4q27 | 1.249 | 0.203 | 2.36e-05
|
FABP7 | fatty acid binding protein 7, brain | 6q22-q23 | 1.247 | 0.277 | 6.35e-09
|
CCL15-CCL14 | CCL15-CCL14 readthrough (NMD candidate) | 17q12 | 1.245 | 0.245 | 3.16e-07
|
STON1-GTF2A1L | STON1-GTF2A1L readthrough | 2p16.3 | 1.243 | 0.047 | 0.329
|
ATP4A | ATPase, H+/K+ exchanging, alpha polypeptide | 19q13.1 | 1.21 | 0.244 | 3.65e-07
|
KLK12 | kallikrein-related peptidase 12 | 19q13.33 | 1.208 | 0.151 | 0.00178
|
CYP2B6 | cytochrome P450, family 2, subfamily B, polypeptide 6 | 19q13.2 | 1.207 | 0.175 | 0.000284
|
NR0B1 | nuclear receptor subfamily 0, group B, member 1 | Xp21.3 | 1.207 | 0.12 | 0.0131
|
WFDC12 | WAP four-disulfide core domain 12 | 20q13.12 | 1.206 | 0.147 | 0.0024
|
NBPF6 | neuroblastoma breakpoint family, member 6 | 1p13.3 | 1.194 | 0.218 | 5.54e-06
|
CRNN | cornulin | 1q21 | 1.192 | 0.062 | 0.198
|
CYP2C19 | cytochrome P450, family 2, subfamily C, polypeptide 19 | 10q24 | 1.19 | 0.164 | 0.000696
|
KIAA0408 | KIAA0408 | 6q22.33 | 1.19 | 0.091 | 0.0594
|
IGFL3 | IGF-like family member 3 | 19q13.32 | 1.186 | 0.194 | 5.52e-05
|
GBA3 | glucosidase, beta, acid 3 (gene/pseudogene) | 4p15.2 | 1.184 | 0.324 | 8.67e-12
|
SLC30A8 | solute carrier family 30 (zinc transporter), member 8 | 8q24.11 | 1.179 | 0.209 | 1.37e-05
|
NKX2-5 | NK2 homeobox 5 | 5q34 | 1.171 | 0.185 | 0.000119
|
B4GALNT2 | beta-1,4-N-acetyl-galactosaminyl transferase 2 | 17q21.33 | 1.167 | 0.015 | 0.76
|
LDHAL6A | lactate dehydrogenase A-like 6A | 11p15.1 | 1.164 | 0.259 | 6.26e-08
|
UGT2A3 | UDP glucuronosyltransferase 2 family, polypeptide A3 | 4q13.2 | 1.163 | 0.195 | 5.36e-05
|
GLB1L3 | galactosidase, beta 1-like 3 | 11q25 | 1.163 | 0.271 | 1.5e-08
|
TRIML2 | tripartite motif family-like 2 | 4q35.2 | 1.161 | 0.104 | 0.0322
|
FGA | fibrinogen alpha chain | 4q28 | 1.153 | 0.226 | 2.45e-06
|
LRRC7 | leucine rich repeat containing 7 | 1p31.1 | 1.152 | 0.186 | 0.000114
|
LHFPL3-AS2 | LHFPL3 antisense RNA 2 | 7q22.3 | 1.142 | 0.265 | 2.94e-08
|
SPINK6 | serine peptidase inhibitor, Kazal type 6 | 5q32 | 1.137 | 0.171 | 0.000399
|
FGB | fibrinogen beta chain | 4q28 | 1.134 | 0.217 | 6.09e-06
|
LGSN | lengsin, lens protein with glutamine synthetase domain | 6q12 | 1.131 | 0.317 | 2.65e-11
|
LRRC3B | leucine rich repeat containing 3B | 3p24 | 1.122 | 0.166 | 0.000586
|
SST | somatostatin | 3q28 | 1.12 | 0.225 | 2.9e-06
|
PPAN-P2RY11 | PPAN-P2RY11 readthrough | 19p13.2 | 1.12 | 0.048 | 0.322
|
LHFPL4 | lipoma HMGIC fusion partner-like 4 | 3p25.3 | 1.114 | 0.105 | 0.0305
|
DAZ1 | deleted in azoospermia 1 | Yq11.223 | 1.108 | 0.189 | 8.9e-05
|
CYP1A2 | cytochrome P450, family 1, subfamily A, polypeptide 2 | 15q24.1 | 1.1 | 0.301 | 2.81e-10
|
ZFP42 | ZFP42 zinc finger protein | 4q35.2 | 1.1 | 0.116 | 0.0166
|
OCA2 | oculocutaneous albinism II | 15q12 | 1.098 | 0.137 | 0.00472
|
TBL1Y | transducin (beta)-like 1, Y-linked | Yp11.2 | 1.095 | 0.126 | 0.00899
|
THRSP | thyroid hormone responsive | 11q14.1 | 1.095 | 0.227 | 2.32e-06
|
PGC | progastricsin (pepsinogen C) | 6p21.1 | 1.093 | 0.172 | 0.000366
|
TKTL1 | transketolase-like 1 | Xq28 | 1.092 | 0.227 | 2.29e-06
|
MRGPRX2 | MAS-related GPR, member X2 | 11p15.1 | 1.084 | 0.203 | 2.4e-05
|
C4BPA | complement component 4 binding protein, alpha | 1q32 | 1.076 | 0.181 | 0.00017
|
GLP2R | glucagon-like peptide 2 receptor | 17p13.3 | 1.076 | 0.06 | 0.213
|
SCGB2A1 | secretoglobin, family 2A, member 1 | 11q13 | 1.072 | 0.117 | 0.0157
|
CDH16 | cadherin 16, KSP-cadherin | 16q22.1 | 1.071 | 0.097 | 0.0445
|
THEG | theg spermatid protein | 19p13.3 | 1.071 | 0.139 | 0.00398
|
HSFY2 | heat shock transcription factor, Y-linked 2 | Yq11.221 | 1.068 | 0.16 | 0.000935
|
TAC1 | tachykinin, precursor 1 | 7q21-q22 | 1.064 | 0.177 | 0.000233
|
C6orf15 | chromosome 6 open reading frame 15 | 6p21 | 1.063 | 0.171 | 0.000384
|
TSPEAR-AS2 | TSPEAR antisense RNA 2 | 21q22.3 | 1.062 | 0.249 | 2.03e-07
|
LGALS9B | lectin, galactoside-binding, soluble, 9B | 17p11.2 | 1.061 | -0.067 | 0.17
|
OPRK1 | opioid receptor, kappa 1 | 8q11.2 | 1.057 | 0.242 | 4.76e-07
|
SPRR4 | small proline-rich protein 4 | 1q21.3 | 1.054 | 0.08 | 0.0989
|
TMEM189-UBE2V1 | TMEM189-UBE2V1 readthrough | 20q13.13 | 1.049 | 0.052 | 0.28
|
LRRTM3 | leucine rich repeat transmembrane neuronal 3 | 10q22.1 | 1.047 | 0.16 | 0.000895
|
WIF1 | WNT inhibitory factor 1 | 12q14.2 | 1.043 | 0.106 | 0.0286
|
TPO | thyroid peroxidase | 2p25 | 1.04 | 0.033 | 0.497
|
SSTR5 | somatostatin receptor 5 | 16p13.3 | 1.04 | 0.041 | 0.396
|
PIK3C2G | phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 gamma | 12p12 | 1.036 | 0.055 | 0.254
|
CTAG1B | cancer/testis antigen 1B | Xq28 | 1.034 | 0.298 | 3.85e-10
|
MAGEA10 | melanoma antigen family A10 | Xq28 | 1.03 | 0.202 | 2.69e-05
|
LOR | loricrin | 1q21 | 1.03 | 0.11 | 0.023
|
PAK3 | p21 protein (Cdc42/Rac)-activated kinase 3 | Xq22.3 | 1.029 | 0.126 | 0.00928
|
PWRN1 | Prader-Willi region non-protein coding RNA 1 | 15q11.2 | 1.027 | 0.17 | 0.000414
|
SEMG1 | semenogelin I | 20q12-q13.2 | 1.023 | 0.168 | 0.000491
|
SLC10A1 | solute carrier family 10 (sodium/bile acid cotransporter), member 1 | 14q24.2 | 1.02 | 0.128 | 0.00823
|
C14orf105 | chromosome 14 open reading frame 105 | 14q22.2 | 1.019 | 0.165 | 0.000639
|
FOXN4 | forkhead box N4 | 12q24.12 | 1.019 | 0.204 | 2.16e-05
|
LMO1 | LIM domain only 1 (rhombotin 1) | 11p15 | 1.016 | 0.095 | 0.0494
|
GKN1 | gastrokine 1 | 2p13.3 | 1.011 | 0.065 | 0.18
|
MAGEB2 | melanoma antigen family B2 | Xp21.3 | 1.011 | 0.277 | 6.51e-09
|
TUSC5 | tumor suppressor candidate 5 | 17p13.3 | 1.01 | 0.086 | 0.0767
|
BRINP3 | bone morphogenetic protein/retinoic acid inducible neural-specific 3 | 1q31.1 | 1.009 | 0.091 | 0.061
|
APOA2 | apolipoprotein A-II | 1q23.3 | 1.008 | 0.255 | 1.04e-07
|
PGM5-AS1 | PGM5 antisense RNA 1 | 9q21.11 | 1.007 | 0.134 | 0.00547
|
CYP2A6 | cytochrome P450, family 2, subfamily A, polypeptide 6 | 19q13.2 | 1.007 | 0.119 | 0.0138
|
SCGB1A1 | secretoglobin, family 1A, member 1 (uteroglobin) | 11q12.3 | 1.004 | 0.055 | 0.253
|
SERPINB11 | serpin peptidase inhibitor, clade B (ovalbumin), member 11 (gene/pseudogene) | 18q21.33 | 1.004 | 0.06 | 0.214
|
KLK2 | kallikrein-related peptidase 2 | 19q13.33 | 1.001 | 0.215 | 7.41e-06
|
GPR12 | G protein-coupled receptor 12 | 13q12 | 0.999 | 0.041 | 0.403
|
TUBA3E | tubulin, alpha 3e | 2q21.1 | 0.995 | 0.208 | 1.6e-05
|
ORM1 | orosomucoid 1 | 9q32 | 0.993 | 0.188 | 9.57e-05
|
OOEP | oocyte expressed protein | 6q13 | 0.991 | 0.131 | 0.00692
|
PAH | phenylalanine hydroxylase | 12q22-q24.2 | 0.989 | 0.281 | 4.23e-09
|
ZMAT4 | zinc finger, matrin-type 4 | 8p11.21 | 0.988 | 0.201 | 3.02e-05
|
IRX6 | iroquois homeobox 6 | 16q12.2 | 0.985 | 0.187 | 0.000106
|
SNTG1 | syntrophin, gamma 1 | 8q11.21 | 0.985 | 0.182 | 0.000154
|
SUMO1P1 | SUMO1 pseudogene 1 | 20q13.2 | 0.984 | 0.174 | 0.000318
|
MS4A8 | membrane-spanning 4-domains, subfamily A, member 8 | 11q12 | 0.984 | 0.022 | 0.647
|
TM4SF4 | transmembrane 4 L six family member 4 | 3q25 | 0.981 | 0.205 | 2.03e-05
|
ODAM | odontogenic, ameloblast asssociated | 4q13.3 | 0.977 | 0.174 | 3e-04
|
FOXA2 | forkhead box A2 | 20p11 | 0.977 | 0.067 | 0.164
|
RPTN | repetin | 1q21.3 | 0.973 | 0.018 | 0.714
|
ZNF676 | zinc finger protein 676 | 19p12 | 0.968 | 0.259 | 6.67e-08
|
TTR | transthyretin | 18q12.1 | 0.965 | 0.282 | 3.68e-09
|
LHX1 | LIM homeobox 1 | 17q12 | 0.954 | 0.078 | 0.109
|
FOXI1 | forkhead box I1 | 5q34 | 0.953 | 0.165 | 0.000606
|
DSG4 | desmoglein 4 | 18q12.1 | 0.953 | 0.062 | 0.204
|
UNC13C | unc-13 homolog C (C. elegans) | 15q21.3 | 0.951 | 0.189 | 9.02e-05
|
CLEC3A | C-type lectin domain family 3, member A | 16q23 | 0.95 | 0.07 | 0.151
|
AMTN | amelotin | 4q13.3 | 0.948 | 0.013 | 0.795
|
ASB5 | ankyrin repeat and SOCS box containing 5 | 4q34.1 | 0.946 | 0.064 | 0.183
|
SFRP5 | secreted frizzled-related protein 5 | 10q24 | 0.946 | 0.074 | 0.125
|
NOL4 | nucleolar protein 4 | 18q12 | 0.944 | 0.104 | 0.0316
|
C9orf171 | cilia and flagella associated protein 77 | 9q34.13 | 0.943 | 0.14 | 0.00365
|
AMBP | alpha-1-microglobulin/bikunin precursor | 9q32-q33 | 0.943 | 0.201 | 2.98e-05
|
SEZ6L | seizure related 6 homolog (mouse)-like | 22q12.1 | 0.943 | 0.144 | 0.00295
|
SPDYC | speedy/RINGO cell cycle regulator family member C | 11q13.1 | 0.942 | 0.215 | 7.8e-06
|
KRT24 | keratin 24, type I | 17q21.2 | 0.942 | 0.087 | 0.0717
|
CFHR1 | complement factor H-related 1 | 1q32 | 0.941 | 0.115 | 0.0174
|
SLC6A15 | solute carrier family 6 (neutral amino acid transporter), member 15 | 12q21.31 | 0.938 | 0.103 | 0.0326
|
KRT75 | keratin 75, type II | 12q13.13 | 0.934 | -0.005 | 0.91
|
PNLDC1 | poly(A)-specific ribonuclease (PARN)-like domain containing 1 | 6q25.3 | 0.934 | 0.213 | 9.05e-06
|
SYT10 | synaptotagmin X | 12p11 | 0.932 | 0.117 | 0.0154
|
LIN28B | lin-28 homolog B (C. elegans) | 6q21 | 0.931 | 0.225 | 2.74e-06
|
NPAP1 | nuclear pore associated protein 1 | 15q11.2 | 0.927 | 0.143 | 0.00319
|
WT1-AS | WT1 antisense RNA | 11p13 | 0.926 | 0.073 | 0.133
|
CPNE6 | copine VI (neuronal) | 14q11.2 | 0.925 | 0.127 | 0.00863
|
CSMD3 | CUB and Sushi multiple domains 3 | 8q23.3 | 0.924 | 0.087 | 0.0715
|
HS3ST4 | heparan sulfate (glucosamine) 3-O-sulfotransferase 4 | 16p11.2 | 0.923 | 0.105 | 0.0306
|
CADM2 | cell adhesion molecule 2 | 3p12.2 | 0.923 | 0.141 | 0.00343
|
ALX1 | ALX homeobox 1 | 12q21.31 | 0.922 | 0.121 | 0.0123
|
FMN2 | formin 2 | 1q43 | 0.922 | 0.16 | 0.000898
|
TEX15 | testis expressed 15 | 8p22 | 0.918 | 0.086 | 0.0763
|
F2 | coagulation factor II (thrombin) | 11p11.2 | 0.915 | 0.223 | 3.53e-06
|
NXPH2 | neurexophilin 2 | 2q22.1 | 0.913 | 0.122 | 0.0116
|
PCK1 | phosphoenolpyruvate carboxykinase 1 (soluble) | 20q13.31 | 0.913 | 0.154 | 0.0014
|
PIP | prolactin-induced protein | 7q34 | 0.912 | -0.001 | 0.977
|
HAVCR1 | hepatitis A virus cellular receptor 1 | 5q33.2 | 0.912 | 0.159 | 0.000996
|
PAEP | progestagen-associated endometrial protein | 9q34 | 0.911 | 0.152 | 0.00161
|
SSTR5-AS1 | SSTR5 antisense RNA 1 | 16p13.3 | 0.905 | 0.016 | 0.737
|
KCNJ16 | potassium channel, inwardly rectifying subfamily J, member 16 | 17q24.3 | 0.904 | 0.117 | 0.0156
|
SOST | sclerostin | 17q12-q21 | 0.9 | 0.06 | 0.216
|
CASR | calcium-sensing receptor | 3q21.1 | 0.898 | 0.133 | 0.00584
|
HAND1 | heart and neural crest derivatives expressed 1 | 5q33 | 0.895 | 0.06 | 0.212
|
ADGRG7 | adhesion G protein-coupled receptor G7 | 3q12.3 | 0.893 | 0.111 | 0.0218
|
TFAP2B | transcription factor AP-2 beta (activating enhancer binding protein 2 beta) | 6p12 | 0.889 | 0.113 | 0.0196
|
NKX6-1 | NK6 homeobox 1 | 4q21.33 | 0.887 | 0.202 | 2.73e-05
|
GLP1R | glucagon-like peptide 1 receptor | 6p21 | 0.886 | 0.126 | 0.00926
|
C6 | complement component 6 | 5p13.1 | 0.885 | 0.157 | 0.00116
|
KCNB1 | potassium channel, voltage gated Shab related subfamily B, member 1 | 20q13.2 | 0.884 | -0.01 | 0.838
|
TRIM15 | tripartite motif containing 15 | 6p21.33 | 0.884 | 0.115 | 0.0178
|
PCDHAC1 | protocadherin alpha subfamily C, 1 | 5q31 | 0.883 | 0.014 | 0.779
|
LDHC | lactate dehydrogenase C | 11p15.1 | 0.88 | 0.163 | 0.000755
|
NELL1 | neural EGFL like 1 | 11p15.1 | 0.879 | 0.087 | 0.0719
|
C11orf87 | chromosome 11 open reading frame 87 | 11q22.3 | 0.878 | 0.064 | 0.186
|
UGT2B28 | UDP glucuronosyltransferase 2 family, polypeptide B28 | 4q13.3 | 0.875 | 0.036 | 0.464
|
ITLN2 | intelectin 2 | 1q22-q23.5 | 0.873 | 0.148 | 0.00222
|
KRT40 | keratin 40, type I | 17q21.2 | 0.87 | 0.128 | 0.00828
|
RIMS1 | regulating synaptic membrane exocytosis 1 | 6q12-q13 | 0.868 | 0.078 | 0.106
|
ARSF | arylsulfatase F | Xp22.3 | 0.865 | 0.031 | 0.527
|
ART4 | ADP-ribosyltransferase 4 (Dombrock blood group) | 12q13.2-q13.3 | 0.864 | 0.12 | 0.0129
|
SPINK7 | serine peptidase inhibitor, Kazal type 7 (putative) | 5q32 | 0.861 | 0.07 | 0.151
|
MYPN | myopalladin | 10q22.1 | 0.86 | 0.05 | 0.306
|
PSG5 | pregnancy specific beta-1-glycoprotein 5 | 19q13.2 | 0.857 | 0.068 | 0.162
|
AGR3 | anterior gradient 3, protein disulphide isomerase family member | 7p21.1 | 0.854 | 0.007 | 0.888
|
FCAMR | Fc receptor, IgA, IgM, high affinity | 1q32.1 | 0.854 | 0.043 | 0.375
|
CFAP47 | cilia and flagella associated protein 47 | Xp21.1 | 0.852 | 0.177 | 0.000252
|
LINGO2 | leucine rich repeat and Ig domain containing 2 | 9p21.2 | 0.851 | 0.01 | 0.841
|
KLK7 | kallikrein-related peptidase 7 | 19q13.33 | 0.851 | 0.058 | 0.229
|
CMA1 | chymase 1, mast cell | 14q12 | 0.848 | 0.05 | 0.301
|
PCDH11X | protocadherin 11 X-linked | Xq21.3 | 0.848 | 0.075 | 0.12
|
FAM224B | family with sequence similarity 224, member B (non-protein coding) | Yq11.221 | 0.846 | 0.068 | 0.161
|
FOXI2 | forkhead box I2 | 10q26.2 | 0.845 | 0.06 | 0.219
|
TCERG1L | transcription elongation regulator 1-like | 10q26.3 | 0.844 | 0.062 | 0.204
|
ANGPTL7 | angiopoietin-like 7 | 1p36 | 0.843 | 0.042 | 0.392
|
CHRM2 | cholinergic receptor, muscarinic 2 | 7q35-q36 | 0.841 | 0.052 | 0.284
|
C10orf90 | chromosome 10 open reading frame 90 | 10q26.2 | 0.839 | 0.168 | 0.000504
|
HMSD | histocompatibility (minor) serpin domain containing | 18q21.33 | 0.827 | 0.06 | 0.216
|
GABRQ | gamma-aminobutyric acid (GABA) A receptor, theta | Xq28 | 0.825 | 0.017 | 0.734
|
PLA2G3 | phospholipase A2, group III | 22q12.2 | 0.824 | 0.076 | 0.117
|
MLIP | muscular LMNA-interacting protein | 6p12.2-p12.1 | 0.822 | -0.013 | 0.788
|
LINC00473 | long intergenic non-protein coding RNA 473 | 6q27 | 0.815 | 0.085 | 0.0794
|
BRINP2 | bone morphogenetic protein/retinoic acid inducible neural-specific 2 | 1q24 | 0.815 | 0.127 | 0.00874
|
ROS1 | ROS proto-oncogene 1 , receptor tyrosine kinase | 6q21-q22 | 0.815 | 0.09 | 0.0619
|
SLC26A5 | solute carrier family 26 (anion exchanger), member 5 | 7q22 | 0.809 | 0.078 | 0.109
|
TCL6 | T-cell leukemia/lymphoma 6 (non-protein coding) | 14q32.1 | 0.805 | 0.122 | 0.0119
|
ADH1A | alcohol dehydrogenase 1A (class I), alpha polypeptide | 4q23 | 0.801 | 0.116 | 0.0163
|
ALPPL2 | alkaline phosphatase, placental-like 2 | 2q37 | 0.799 | 0.063 | 0.192
|
C11orf86 | chromosome 11 open reading frame 86 | 11q13.1 | 0.798 | 0.11 | 0.0237
|
PENK | proenkephalin | 8q23-q24 | 0.795 | 0.031 | 0.525
|
PHGR1 | proline/histidine/glycine-rich 1 | 15q15.1 | 0.789 | 0.068 | 0.162
|
GUCA2A | guanylate cyclase activator 2A (guanylin) | 1p35-p34 | 0.784 | 0.243 | 3.95e-07
|
IGFN1 | immunoglobulin-like and fibronectin type III domain containing 1 | 1q32.1 | 0.781 | 0.086 | 0.0766
|
PMP2 | peripheral myelin protein 2 | 8q21.3-q22.1 | 0.78 | 0.032 | 0.513
|
UGT1A7 | UDP glucuronosyltransferase 1 family, polypeptide A7 | 2q37 | 0.779 | -0.009 | 0.855
|
PRSS1 | protease, serine, 1 (trypsin 1) | 7q34 | 0.778 | 0.004 | 0.938
|
PAPPA2 | pappalysin 2 | 1q25.2 | 0.776 | 0.102 | 0.0343
|
SPRR2E | small proline-rich protein 2E | 1q21-q22 | 0.776 | 0.006 | 0.908
|
HSPB3 | heat shock 27kDa protein 3 | 5q11.2 | 0.775 | 0.028 | 0.562
|
CNR2 | cannabinoid receptor 2 (macrophage) | 1p | 0.774 | -0.019 | 0.689
|
PLA2G4E | phospholipase A2, group IVE | 15q15.1 | 0.768 | 0.002 | 0.975
|
PKLR | pyruvate kinase, liver and RBC | 1q22 | 0.766 | 0.264 | 3.66e-08
|
LCE1E | late cornified envelope 1E | 1q21.3 | 0.765 | 0.031 | 0.518
|
CGB8 | chorionic gonadotropin, beta polypeptide 8 | 19q13.32 | 0.764 | 0.01 | 0.829
|
NPFFR2 | neuropeptide FF receptor 2 | 4q21 | 0.764 | 0.205 | 2.08e-05
|
ZNF536 | zinc finger protein 536 | 19q13.11 | 0.762 | 0.08 | 0.0969
|
UG0898H09 | | | 0.76 | 0.013 | 0.795
|
KCNG3 | potassium channel, voltage gated modifier subfamily G, member 3 | 2p21 | 0.759 | 0.089 | 0.0659
|
UTS2 | urotensin 2 | 1p36 | 0.758 | 0.083 | 0.0866
|
HEPACAM2 | HEPACAM family member 2 | 7q21.3 | 0.753 | 0.134 | 0.00562
|
NRXN1 | neurexin 1 | 2p16.3 | 0.753 | 0.021 | 0.668
|
BCORP1 | BCL6 corepressor pseudogene 1 | Yq11.222 | 0.752 | 0.043 | 0.378
|
TTLL6 | tubulin tyrosine ligase-like family member 6 | 17q21.32 | 0.752 | 0.087 | 0.0723
|
PSG4 | pregnancy specific beta-1-glycoprotein 4 | 19q13.2 | 0.752 | 0.027 | 0.573
|
HSD3B1 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 | 1p12 | 0.746 | 0.2 | 3.19e-05
|
ADH4 | alcohol dehydrogenase 4 (class II), pi polypeptide | 4q23 | 0.742 | 0.161 | 0.000842
|
C1orf110 | coiled-coil domain containing 190 | 1q23.3 | 0.742 | -0.014 | 0.775
|
SAA4 | serum amyloid A4, constitutive | 11p15.1-p14 | 0.742 | 0.07 | 0.146
|
ITIH2 | inter-alpha-trypsin inhibitor heavy chain 2 | 10p14 | 0.742 | 0.078 | 0.107
|
TMPRSS11D | transmembrane protease, serine 11D | 4q13.2 | 0.742 | -0.038 | 0.431
|
HABP2 | hyaluronan binding protein 2 | 10q25.3 | 0.741 | 0.052 | 0.28
|
NYAP2 | neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 2 | 2q36.3 | 0.739 | 0.122 | 0.0114
|
CD300LG | CD300 molecule-like family member g | 17q21.31 | 0.739 | 0.069 | 0.152
|
FEZF1 | FEZ family zinc finger 1 | 7q31.32 | 0.736 | 0.07 | 0.146
|
SPINK4 | serine peptidase inhibitor, Kazal type 4 | 9p13.3 | 0.734 | 0.084 | 0.0848
|
SGCG | sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein) | 13q12-q13 | 0.734 | 0.081 | 0.0939
|
TLX1 | T-cell leukemia homeobox 1 | 10q24.32 | 0.732 | 0.172 | 0.00036
|
NR1H4 | nuclear receptor subfamily 1, group H, member 4 | 12q23.1 | 0.732 | 0.158 | 0.00106
|
TCP11 | t-complex 11, testis-specific | 6p21.31 | 0.731 | 0.065 | 0.178
|
CHGA | chromogranin A | 14q32 | 0.73 | 0.052 | 0.287
|
CTNNA3 | catenin (cadherin-associated protein), alpha 3 | 10q21 | 0.727 | 0.152 | 0.00163
|
ANKFN1 | ankyrin-repeat and fibronectin type III domain containing 1 | 17q23.2 | 0.725 | -0.013 | 0.796
|
C10orf82 | chromosome 10 open reading frame 82 | 10q26.12 | 0.725 | 0.063 | 0.197
|
CBLN2 | cerebellin 2 precursor | 18q22.3 | 0.72 | 0.073 | 0.133
|
SULT2A1 | sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1 | 19q13.3 | 0.718 | 0.138 | 0.00417
|
EPYC | epiphycan | 12q21 | 0.715 | 0.038 | 0.439
|
ZSCAN1 | zinc finger and SCAN domain containing 1 | 19q13.43 | 0.714 | 0.2 | 3.18e-05
|
TTTY14 | testis-specific transcript, Y-linked 14 (non-protein coding) | Yq11.222 | 0.714 | 0.038 | 0.435
|
SCN7A | sodium channel, voltage gated, type VII alpha subunit | 2q21-q23 | 0.71 | 0.018 | 0.713
|
SFTA2 | surfactant associated 2 | 6p21.3 | 0.702 | 0.142 | 0.00331
|
CBLN1 | cerebellin 1 precursor | 16q12.1 | 0.7 | 0.113 | 0.0195
|
FOXD3 | forkhead box D3 | 1p31.3 | 0.699 | 0.016 | 0.734
|
ACSM6 | acyl-CoA synthetase medium-chain family member 6 | 10q23.33 | 0.699 | 0.158 | 0.00105
|
SLC30A10 | solute carrier family 30, member 10 | 1q41 | 0.695 | 0.096 | 0.0483
|
TMEM132C | transmembrane protein 132C | 12q24.32 | 0.695 | 0.008 | 0.862
|
ABCB11 | ATP-binding cassette, sub-family B (MDR/TAP), member 11 | 2q24 | 0.693 | -0.047 | 0.328
|
C4BPB | complement component 4 binding protein, beta | 1q32 | 0.693 | 0.194 | 5.68e-05
|
CRH | corticotropin releasing hormone | 8q13 | 0.692 | 0.177 | 0.000247
|
CLEC17A | C-type lectin domain family 17, member A | 19p13.12 | 0.691 | -0.001 | 0.977
|
SMPX | small muscle protein, X-linked | Xp22.2-p22.1 | 0.687 | 0.098 | 0.0437
|
LPPR1 | phospholipid phosphatase related 1 | 9q31.1 | 0.669 | 0.155 | 0.00131
|
LINC00518 | long intergenic non-protein coding RNA 518 | 6p24.3 | 0.668 | -0.042 | 0.39
|
PCDHA10 | protocadherin alpha 10 | 5q31 | 0.665 | 0.089 | 0.0652
|
MAGEA4 | melanoma antigen family A4 | Xq28 | 0.656 | 0.227 | 2.23e-06
|
CSMD1 | CUB and Sushi multiple domains 1 | 8p23.2 | 0.656 | 0.093 | 0.0537
|
KRT34 | keratin 34, type I | 17q21.2 | 0.649 | 0.011 | 0.82
|
FAM25BP | family with sequence similarity 25, member B, pseudogene | 10q11.22 | 0.635 | 0.048 | 0.318
|
CYP2C9 | cytochrome P450, family 2, subfamily C, polypeptide 9 | 10q24.1 | 0.633 | 0.076 | 0.115
|
KCNK10 | potassium channel, two pore domain subfamily K, member 10 | 14q31 | 0.632 | 0.037 | 0.45
|
SLC34A2 | solute carrier family 34 (type II sodium/phosphate cotransporter), member 2 | 4p15.2 | 0.631 | 0.098 | 0.0436
|
IL17C | interleukin 17C | 16q24 | 0.628 | 0.128 | 0.00835
|
SCG3 | secretogranin III | 15q21.2 | 0.605 | 0.127 | 0.00861
|
SULT1B1 | sulfotransferase family, cytosolic, 1B, member 1 | 4q13.3 | 0.598 | 0.144 | 0.00284
|
OR10H1 | olfactory receptor, family 10, subfamily H, member 1 | 19p13.1 | 0.597 | 0.138 | 0.00444
|
RNF186 | ring finger protein 186 | 1p36.13 | 0.593 | 0.191 | 7.42e-05
|
LINC00162 | long intergenic non-protein coding RNA 162 | 21q22.3 | 0.586 | 0.074 | 0.125
|
CXorf49B | chromosome X open reading frame 49B | Xq13.1 | 0.57 | 0.021 | 0.667
|
TSIX | TSIX transcript, XIST antisense RNA | Xq13.2 | 0.552 | 0.133 | 0.0059
|
CDIPT-AS1 | CDIPT antisense RNA 1 (head to head) | 16p11.2 | 0.547 | 0.157 | 0.00117
|
FXYD4 | FXYD domain containing ion transport regulator 4 | 10q11.21 | 0.532 | 0.067 | 0.169
|
MUC21 | mucin 21, cell surface associated | 6p21.33 | 0.521 | 0.019 | 0.701
|
TEPP | testis, prostate and placenta expressed | 16q13 | 0.521 | 0.091 | 0.0591
|
FRMPD1 | FERM and PDZ domain containing 1 | 9p13.1 | 0.52 | 0.188 | 9.52e-05
|
LEP | leptin | 7q31 | 0.513 | 0.162 | 0.000802
|
SOSTDC1 | sclerostin domain containing 1 | 7p21.2 | 0.507 | 0.069 | 0.157
|
SLC45A2 | solute carrier family 45, member 2 | 5p13.3 | 0.505 | 0.147 | 0.00231
|
CTNND2 | catenin (cadherin-associated protein), delta 2 | 5p15.2 | 0.502 | 0.119 | 0.0137
|
KRT77 | keratin 77, type II | 12q13.13 | 0.469 | -0.07 | 0.146
|
PCDHA3 | protocadherin alpha 3 | 5q31 | 0.463 | 0.063 | 0.196
|
UNC80 | unc-80 homolog (C. elegans) | 2q35 | 0.463 | 0.089 | 0.0672
|
CLEC2L | C-type lectin domain family 2, member L | 7q34 | 0.452 | 0.212 | 9.99e-06
|
CYP26A1 | cytochrome P450, family 26, subfamily A, polypeptide 1 | 10q23-q24 | 0.452 | 0.15 | 0.00191
|
ADAMTS19 | ADAM metallopeptidase with thrombospondin type 1 motif, 19 | 5q23.3 | 0.446 | 0.101 | 0.0378
|
CNDP1 | carnosine dipeptidase 1 (metallopeptidase M20 family) | 18q22.3 | 0.441 | 0.087 | 0.0738
|
ITLN1 | intelectin 1 (galactofuranose binding) | 1q21.3 | 0.436 | 0.157 | 0.00114
|
PIWIL2 | piwi-like RNA-mediated gene silencing 2 | 8p24 | 0.436 | 0.044 | 0.368
|
FRMPD2 | FERM and PDZ domain containing 2 | 10q11 | 0.432 | 0.058 | 0.234
|
GSTM2P1 | glutathione S-transferase mu 2 (muscle) pseudogene 1 | 6q21 | 0.428 | 0.095 | 0.0509
|
FTCD | formimidoyltransferase cyclodeaminase | 21q22.3 | 0.403 | 0.279 | 4.97e-09
|
LHFPL1 | lipoma HMGIC fusion partner-like 1 | Xq23 | 0.396 | 0.064 | 0.19
|
VNN3 | vanin 3 | 6q23.2 | 0.374 | 0.004 | 0.927
|
SHD | Src homology 2 domain containing transforming protein D | 19p13.3 | 0.352 | 0.273 | 1.18e-08
|
GTSF1 | gametocyte specific factor 1 | 12q13.2 | 0.347 | 0.205 | 2.05e-05
|
LOC284578 | | | 0.343 | 0.071 | 0.141
|
DUSP13 | dual specificity phosphatase 13 | 10q23.1 | 0.34 | 0.08 | 0.0974
|
LINC01018 | long intergenic non-protein coding RNA 1018 | 5p15.31 | 0.338 | 0.119 | 0.0137
|
CLEC18C | C-type lectin domain family 18, member C | 16q22.1 | 0.336 | 0.189 | 9.11e-05
|
GCKR | glucokinase (hexokinase 4) regulator | 2p23 | 0.327 | 0.227 | 2.28e-06
|
DLGAP1 | discs, large (Drosophila) homolog-associated protein 1 | 18p11.3 | 0.308 | 0.161 | 0.000875
|
MTTP | microsomal triglyceride transfer protein | 4q24 | 0.306 | 0.054 | 0.265
|
CHD5 | chromodomain helicase DNA binding protein 5 | 1p36.3 | 0.305 | -0.004 | 0.926
|
HRASLS | HRAS-like suppressor | 3q29 | 0.292 | 0.099 | 0.0408
|
TRIM54 | tripartite motif containing 54 | 2p23.3 | 0.283 | 0.161 | 0.000882
|
CEACAM7 | carcinoembryonic antigen-related cell adhesion molecule 7 | 19q13.2 | 0.27 | -0.075 | 0.124
|
ERBB4 | erb-b2 receptor tyrosine kinase 4 | 2q33.3-q34 | 0.268 | 0.031 | 0.526
|
APOA1 | apolipoprotein A-I | 11q23-q24 | 0.257 | 0.258 | 7.11e-08
|
FAR2P1 | fatty acyl CoA reductase 2 pseudogene 1 | 2q21.1 | 0.252 | 0.16 | 0.000888
|
SCN4A | sodium channel, voltage gated, type IV alpha subunit | 17q23.3 | 0.236 | 0.115 | 0.0172
|
EFHB | EF-hand domain family, member B | 3p24.3 | 0.234 | 0.125 | 0.00949
|
PRSS50 | protease, serine, 50 | 3p21.31 | 0.213 | 0.198 | 3.97e-05
|
RFXAP | regulatory factor X-associated protein | 13q14 | 0.21 | 0.123 | 0.0112
|
FAF2 | Fas associated factor family member 2 | 5q35.2 | 0.21 | -0.294 | 6.9e-10
|
SH3TC1 | SH3 domain and tetratricopeptide repeats 1 | 4p16.1 | 0.202 | -0.073 | 0.13
|
SOHLH2 | spermatogenesis and oogenesis specific basic helix-loop-helix 2 | 13q13.3 | 0.2 | 0.14 | 0.00371
|
ITGB4 | integrin, beta 4 | 17q25.1 | 0.2 | -0.223 | 3.45e-06
|
C16orf87 | chromosome 16 open reading frame 87 | 16q11.2 | 0.197 | 0.143 | 0.00315
|
ASPH | aspartate beta-hydroxylase | 8q12.1 | 0.197 | -0.189 | 9.14e-05
|
TEX14 | testis expressed 14 | 17q22 | 0.192 | 0.147 | 0.00235
|
SPEF1 | sperm flagellar 1 | 20p13 | 0.19 | 0.085 | 0.0799
|
STAG3 | stromal antigen 3 | 7q22 | 0.19 | 0.171 | 0.000383
|
UGT3A2 | UDP glycosyltransferase 3 family, polypeptide A2 | 5p13.2 | 0.19 | 0.099 | 0.0411
|
NECAB3 | N-terminal EF-hand calcium binding protein 3 | 20q11.21 | 0.189 | 0.216 | 6.92e-06
|
MUC6 | mucin 6, oligomeric mucus/gel-forming | 11p15.5 | 0.187 | 0.159 | 0.000965
|
MARCKS | myristoylated alanine-rich protein kinase C substrate | 6q21 | 0.186 | -0.067 | 0.17
|
JADE1 | jade family PHD finger 1 | 4q26-q27 | 0.183 | 0.172 | 0.00037
|
ARHGEF33 | Rho guanine nucleotide exchange factor (GEF) 33 | 2p22.1 | 0.176 | 0.117 | 0.0152
|
CTAGE15 | CTAGE family, member 15 | 7q35 | 0.174 | -0.007 | 0.89
|
FLVCR1-AS1 | FLVCR1 antisense RNA 1 (head to head) | 1q32.3 | 0.173 | 0.072 | 0.139
|
KRT222 | keratin 222, type II | 17q21.2 | 0.172 | -0.029 | 0.555
|